List of Revvity Signals Customers

Waltham, 2451, MA,
United States
Since 2010, our global team of researchers has been studying Revvity Signals customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Revvity Signals for Clinical Trial Management,Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Revvity Signals for Clinical Trial Management,Laboratory Management include: Eli Lilly, a United States based Life Sciences organisation with 47000 employees and revenues of $45.04 billion, Millipore Sigma, a Merck Company, a United States based Life Sciences organisation with 28000 employees and revenues of $7.00 billion, Camurus, a Sweden based Life Sciences organisation with 250 employees and revenues of $66.0 million, SK Life Science, a United States based Life Sciences organisation with 350 employees and revenues of $55.0 million, Axxam, a Italy based Life Sciences organisation with 200 employees and revenues of $32.0 million and many others.
Contact us if you need a completed and verified list of companies using Revvity Signals, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Revvity Signals customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Old Product | New Product | Category | When | SI |
---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
Axxam | Life Sciences | 200 | $32M | Italy | Revvity | Legacy | Revvity Signals | Clinical Trial Management,Laboratory Management | 2025 | n/a |
![]() |
Camurus | Life Sciences | 250 | $66M | Sweden | Revvity | Legacy | Revvity Signals | Clinical Trial Management,Laboratory Management | 2023 | n/a |
![]() |
Eli Lilly | Life Sciences | 47000 | $45.0B | United States | Revvity | Legacy | Revvity Signals | Clinical Trial Management,Laboratory Management | 2025 | n/a |
|
|
Life Sciences | 28000 | $7.0B | United States | Revvity | Legacy | Revvity Signals | Clinical Trial Management,Laboratory Management | 2025 | n/a |
|
|
Life Sciences | 350 | $55M | United States | Revvity | Legacy | Revvity Signals | Clinical Trial Management,Laboratory Management | 2025 | n/a |
Buyer Intent: Companies Evaluating Revvity Signals
Discover Software Buyers actively Evaluating Enterprise Applications
Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
---|---|---|---|---|---|---|---|---|
No data found |